Table 3: Comparison of HDL-c levels (mmol/L) between pre- and postplacebo intake.
Group (no)Preplacebo intake*
M e a n ± S D 		Postplacebo intake**
M e a n ± S D
A ( 𝑛 = 1 1 ) 1 . 5 5 ± 0 . 3 9 ∗ ∗ ∗ 1 . 5 3 ± 0 . 3 4
B ( 𝑛 = 1 3 ) 1 . 5 8 ± 0 . 4 4 1 . 5 0 ± 0 . 4 2
𝑃 > 0 . 0 5 .
*Preplacebo intake: Group A completed HFC treatment for the first four weeks and started the placebo intake.
**Postplacebo intake: Group A completed the placebo intake for the second four weeks; Group B completed the placebo intake for the first four weeks.
***This value is different from the value of Group A ( 𝑛 = 1 4 ) at posttreatment ( 1 . 5 3 ± 0 . 4 2 , Table 2) because three participants withdrew from the trial. Eleven participants in Group A ( 𝑛 = 1 1 ) completed their test.